Miller School of Medicine: Sylvester Research Identifies Novel Vulnerability in Acute Leukemia Cells
October 30, 2019
October 30, 2019
MIAMI, Florida, Oct. 30 [TNSmedicalresearch-Nature Communications] -- The University of Miami's Miller School of Medicine issued the following news:
Researchers at the NCI-designated Sylvester Comprehensive Cancer Center, working within several departments at the University of Miami Miller School of Medicine, have identified another critical component of the AML1-ETO multi-protein complex that could point the way to more effective therapies for acute myeloid leukemia (AML). AML1-ETO . . .
Researchers at the NCI-designated Sylvester Comprehensive Cancer Center, working within several departments at the University of Miami Miller School of Medicine, have identified another critical component of the AML1-ETO multi-protein complex that could point the way to more effective therapies for acute myeloid leukemia (AML). AML1-ETO . . .